SCIENCE NEWS
Protein Key to Growth of Pancreatic Cancer
Researchers found that nearly three quarters of pancreatic cancer tumors had high levels of a protein known as P110gamma. In laboratory experiments, when production of this protein was blocked, the cancer cells stopped growing. [Press release from EurekAlert! discussing online prepublication in Clinical Cancer Research]
|
|
POLICY NEWS
Diabetes Group Supports Stricter Drug Approval Standards
Tighter safety standards for approval of diabetes drugs are coming to Europe with the cautious support of the European Association for the Study of Diabetes. [European Association for the Study of Diabetes, European Union]
European Medicines Agency Recommends Suspension of Avandia, Avandamet and Avaglim
The European Medicines Agency recommended the suspension of the marketing authorizations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim [European Medicines Agency, European Union]
FDA Significantly Restricts Access to the Diabetes Drug Avandia
The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. [Food and Drug Administration, United States]
Lawmakers Introduce Bipartisan Legislation to Create Jobs and Promote Investment in Life Sciences
U.S. Representatives introduced bipartisan legislation that will provide tax incentives for small and mid-sized businesses to invest in life sciences research and development on a targeted basis. The Life Sciences Jobs and Investment Act of 2010 provides an opportunity to enhance medical innovation, life sciences education and job creation in the United States. [House of Representatives, United States]
NIH and FDA Announce Awards to Advance Regulatory Science
The National Institutes of Health will award $9.4 million over three years to support four research projects in regulatory science. This research is conducted in partnership with the U.S. Food and Drug Administration, which will contribute approximately $950,000. [National Institutes of Health and Food and Drug Administration, United States]
NIH Releases Biennial Report of the Director
Dr. Francis S. Collins, M.D., Ph.D, director of the National Institutes of Health, announced the release of the Biennial Report of the Director, NIH, for fiscal years 2008 and 2009. The report provides an integrated portrait of NIH research activities, making it easy for Congress, advocates and patient groups and the general public to understand the many activities of the agency. [National Institutes of Health, United States]
U.K. Research Leaders Make Final Stand Against Science Cuts
Top officials from six U.K. universities joined Martin Rees, president of the Royal Society, in London in a last-ditch attempt to avert the government’s expected cuts in science funding, which will be detailed in its forthcoming comprehensive spending review, scheduled for release on 20 October. [Royal Society, United Kingdom]
European Medicines Agency Publishes First Review of Orphan Designation
The European Medicines Agency has published the first of its ‘review of orphan designation’ documents. [European Medicines Agency, European Union]
European Medicines Agency Welcomes Adoption of New Pharmacovigilance Legislation by European Parliament
The European Medicines Agency welcomes the adoption of the new pharmacovigilance legislation by the European Parliament. This is a major step towards the legislation coming into force, currently expected for mid-2012. [European Medicines Agency, European Union]
Guidance on Withdrawal of Subjects From Research: Data Retention and Other Related Issues (FR Doc. 2010-23517) [Department of Health and Human Services, United States]
Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting (FR Doc. 2010-23947) [National Institutes of Health, United States]
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting (FR Doc. 2010-23867) [National Institutes of Health, United States]
National Center for Research Resources; Notice of Closed Meeting (FR Doc. 2010-23852) [National Institutes of Health, United States]
Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-23849) [National Institutes of Health, United States]
Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-23860) [National Institutes of Health, United States]
Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-23952) [National Institutes of Health, United States]
National Cancer Institute; Notice of Closed Meetings (FR Doc. 2010-23543) [National Institutes of Health, United States]
National Cancer Institute; Notice of Closed Meetings (FR Doc. 2010-23545) [National Institutes of Health, United States]
|
|
EVENTS (Listed by Date)
35th European Society for Medical Oncology (ESMO) Congress
October 8-12, 2010
Milan, Italy
Fraunhofer Life Science Symposium Leipzig 2010
October 29-30, 2010
Leipzig, Germany
2010 American Pancreatic Association (APA) Annual Meeting
November 3-6, 2010
Chicago, United States
Select Biosciences 2nd International Forum on Stem Cells (2010 IFSC)
November 12-13, 2010
Tianjin, China
Australasian Pancreatic Club Annual Meeting
November 15-16, 2010
Melbourne, Australia
Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction
January 12-17, 2011
Dillon, United States
Keystone Symposia: Obesity
January 12-17, 2011
Keystone, Colorado
2011 Gastrointestinal Cancers Symposium
January 20-22, 2011
San Francisco, United States
Epithelial Plasticity and Epithelial to Mesenchymal Transition
January 21-26, 2011
Vancouver, Canada
Select Biosciences 5th Annual Stem Cells World Congress
January 24-25, 2011
San Diego, United States
Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
January 24-26, 2011
Washington, DC, United States
Joint Conference of the International Association of Pancreatology and the Indian Pancreas Club
February 10-13, 2011
Maradu, India
NEW American Association for Cancer Research (AACR) 102nd Annual Meeting 2011
April 2-6, 2011
Orlando, United States
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Cell Therapy Technologist (Opexa Therapeutics)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!
|
|
|
|
